Funding cuts could cause 3.3 million additional HIV infections by 2030: report
Global HIV assistance is projected to drop by 30 to 40 percent in 2025 compared with 2023, a new UNAID report found.
November 26, 2025
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
Global HIV assistance is projected to drop by 30 to 40 percent in 2025 compared with 2023, a new UNAID report found.
Here's everything DOGE did that affected the LGBTQ+ community at home and abroad.
There are now more ways than ever — including long-acting injectables — to prevent the spread of HIV.
CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory factors."
Yeztugo, generic name lenacapavir, has been approved after nearly eliminating the spread of HIV among trial patients.
Just how far does religious freedom go? Many human rights experts believe it's already gone too far.
Manuel Guerrero, 44, is banned from leaving the country and is about to run out of antiretroviral medication, his brother Enrique tells The Advocate.
The family of 44-year-old Manuel Guerrero say that Qatari authorities have subjected him to torture by depriving him of his HIV medication.
Amando Herrera sold the counterfeit medications that were ultimately prescribed to unsuspecting patients.